Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lane

Showing results (841-850 of 923) with videos related to

Pageof 93
Sort By:
The Journal of Biological Chemistry|September 9, 2020
Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacologyMarcus J G W Ladds, Gergana Popova, Andrés Pastor-Fernández, et al.
Circulation. Cardiovascular Interventions|June 5, 2014
Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery modelFumiyuki Otsuka, Erica Pacheco, Laura E L Perkins, et al.
American Journal of Rhinology & Allergy|September 20, 2024
Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal PolypsZachary M Soler, Zara M Patel, Joaquim Mullol, et al.
Structure (London, England : 1993)|April 8, 2003
Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loopSu Ying Wu, Iain McNae, George Kontopidis, et al.
PNAS Nexus|February 6, 2023
A "grappling hook" interaction connects self-assembly and chaperone activity of Nucleophosmin 1Mihkel Saluri, Axel Leppert, Genis Valentin Gese, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2020
Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responsesSaikiran K Sedimbi, Thomas Hägglöf, Manasa G Garimella, et al.
Structure (London, England : 1993)|December 6, 2003
Insights into cyclin groove recognition: complex crystal structures and inhibitor design through ligand exchangeGeorge Kontopidis, Martin J I Andrews, Campbell McInnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA)Shuhui Lim, Regina Khoo, Khong Ming Peh, et al.
Oncotarget|August 11, 2015
Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant miceAmanda M Goh, Yuezhen Xue, Marc Leushacke, et al.
Blood|February 5, 2005
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survivalAzra J Alvi, Belinda Austen, Victoria J Weston, et al.
Pageof 93

Showing results (841-850 of 923) with videos related to

Sort By:
Pageof 93
The Journal of Biological Chemistry|September 9, 2020
Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacologyMarcus J G W Ladds, Gergana Popova, Andrés Pastor-Fernández, et al.
Circulation. Cardiovascular Interventions|June 5, 2014
Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery modelFumiyuki Otsuka, Erica Pacheco, Laura E L Perkins, et al.
American Journal of Rhinology & Allergy|September 20, 2024
Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal PolypsZachary M Soler, Zara M Patel, Joaquim Mullol, et al.
Structure (London, England : 1993)|April 8, 2003
Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loopSu Ying Wu, Iain McNae, George Kontopidis, et al.
PNAS Nexus|February 6, 2023
A "grappling hook" interaction connects self-assembly and chaperone activity of Nucleophosmin 1Mihkel Saluri, Axel Leppert, Genis Valentin Gese, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2020
Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responsesSaikiran K Sedimbi, Thomas Hägglöf, Manasa G Garimella, et al.
Structure (London, England : 1993)|December 6, 2003
Insights into cyclin groove recognition: complex crystal structures and inhibitor design through ligand exchangeGeorge Kontopidis, Martin J I Andrews, Campbell McInnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA)Shuhui Lim, Regina Khoo, Khong Ming Peh, et al.
Oncotarget|August 11, 2015
Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant miceAmanda M Goh, Yuezhen Xue, Marc Leushacke, et al.
Blood|February 5, 2005
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survivalAzra J Alvi, Belinda Austen, Victoria J Weston, et al.
Pageof 93